PeptAI is an autonomous AI agent network that computationally designs and validates peptide drug candidates, publishing its reasoning traces publicly. PeptAI's Twitter Score is 17 out of 1000 as of August 2026, ranking #56,152 among 483,944 tracked accounts.
PeptAI screens peptide candidates through an eight-gate validation stack, forwarding those that meet a weighted pass threshold to wet-lab partners for physical testing. The platform publishes validation results through BIO Protocol-adjacent infrastructure via Molecule and hands off validated candidates to Adaptyv Bio for wet-lab experiments. Its live research programs target KISS1R for fertility, OX2R for ADHD, and GLP-1R for metabolic health. An OX2R candidate has been published for pre-IND work on Molecule mainnet, though it has not yet entered wet-lab testing.
PeptAI operates within the Base blockchain ecosystem and launched a public $PEPTAI token sale on the BIO Launchpad on May 1, 2026, targeting a $50,000 raise at a $1,000,000 fully diluted valuation. The sale offered 500,000 tokens at $0.10 each, representing 5% of a total supply of 10,000,000 tokens, with 100% unlocked at the token generation event. The platform has been active since 2026 and has published 200 posts to date. PeptAI has been mentioned by 27 accounts, with 68 total mentions.
Who follows PeptAI on X?
The accounts that follow PeptAI include 65 founders, 31 angel investors and 45 influencers. Among them are Avichal Garg - Electric Capital, Jake Brukhman, Zmanian, Agentyoda, SpiderCrypto and DFarmer.